Danazol binding to steroid receptors in human uterine endometrium

article OA: closed CC0 ⤵ 16 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-13

This study investigated the binding affinity of danazol to estrogen and progesterone receptors within human uterine endometrial tissue.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To understand the mechanism of action of danazol, the binding of danazol to multiple classes of intracellular steroid binding proteins was studied in the human uterine endometrium. Danazol bound to endometrial receptors for estrogen, progesterone, and androgen and seemed to bind to endometrial intracellular corticosteroid-binding globulin and sex-hormone-binding globulin. Danazol occupies almost all binding sites of steroids in the steroid target cells in spite of the presence of endogenous steroids. It is speculated that the binding behavior of danazol may be related to its therapeutic effect on endometriosis.

My notes (saved in your browser only)

MeSH descriptors

Danazol Endometrium Pregnadienes Receptors, Androgen Receptors, Estrogen Receptors, Progesterone Receptors, Steroid Binding Sites Danazol Danazol Dose-Response Relationship, Drug Endometrium Female Humans In Vitro Techniques Pregnadienes Receptors, Androgen Receptors, Estrogen Receptors, Progesterone Receptors, Steroid

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (19)

Cited by (16)

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-05-10T10:48:05.941430+00:00
pubmed
last seen: 2026-05-13T22:09:50.790931+00:00
License: CC0 · commercial use OK